Not Signed In - Barr Receives Tentative Approval For A Generic Version Of ZYPREXA(R) Zydis(R) Tablets, 5mg, 10mg, 15mg And 20mg
Fri, 10 Nov 2006 08:00 AM EST
... Barr Pharmaceuticals, Inc. (NYSE: BRL) today announced that its subsidiary, Barr Laboratories, Inc. has received tentative approval from the U.S. Food and Drug Administration (FDA) for its generic version of Eli Lilly and Company's ZYPREXA(R) Zydis(R) (Olanzapine) Orally Disintegrating Tablets, 5mg, 10mg, 15mg and 20mg. [click link for full article] ...
Related Topics
- Olanzapine
- Olanzapine Disintegrating Tablets
- Epstein Barr Virus
- Amlodipine
- Aripiprazole
- Ramipril
- Finasteride
- Carbinoxamine and Pseudoephedrine Tablets
- Meloxicam
- Lp(a)
- Olanzapine Injection
- Dicyclomine
- Vaccine Testing & Approval
- Benazepril
- Carbinoxamine and Pseudoephedrine Extended-Release Tablets
- Lovastatin
- Rabeprazole
- Cyanocobalamin Tablets
- Frequent infections especially with Epstein-Barr virus
- Epstein-Barr Virus (EBV) Infection
email this page
print this page
bookmark this page
feedback on this page
